Xadago

Xadago (safinamide) is an oral medication used alongside levodopa for Parkinson’s disease motor fluctuations. It belongs to the MAO-B inhibitor class, supporting dopamine activity. This overview covers general uses, effects, and safety notes for informational purposes only.

Xadago is primarily used to manage motor fluctuations in Parkinson’s disease when combined with levodopa. It is prescribed to improve 'on' time without troublesome dyskinesia. People often ask, 'what is Xadago used for' to understand its role in symptom control. It is not a standalone treatment for Parkinson’s but works as an adjunct therapy.

Xadago may help reduce off periods and improve mobility during on periods for some individuals. Users sometimes report increased energy or smoother movement after starting treatment. Individual responses vary, and effects are not guaranteed for everyone. It is important to monitor how the medication feels over time.

Store Xadago at room temperature away from moisture and heat. Keep it out of reach of children and pets. Avoid crushing or splitting tablets unless directed by a healthcare provider. Report any unusual symptoms to a medical professional promptly. Always follow storage guidelines on the packaging.

Xadago may interact with other MAO inhibitors, opioids, or certain antidepressants. Alcohol and high-tyramine foods should be used cautiously due to potential reactions. CYP inhibitors or inducers may affect saf inamide levels. Always inform a healthcare provider about all medications being taken to avoid adverse combinations.